| Term 
 | Definition 
 
        | Acts on target tissues (esp liver) through JAK2 (a TK) to initiated signalling pathways; Production of IGF-1(&2) to exert effects;
 Dec insulin sens, inc lipolysis, inc protein synth, inc epiphyseal growth;
 Secretion stimulated by hypoglycemia, insulin;
 Physiologic pulsatile release
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hGH; Replacement therapy in children;
 Tx child - pituitary dwarfism (d/c when growth stops);
 Tx adults - CV dz mortality, AIDS-associated wasting;
 SE child (fewer) - leukemia, inc ICP, nausea;
 SE adult - carpal tunnel, peripheral edema, arthralgia, myalgia;
 CI - leukemia tx
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | D2 receptor agonist; Dec prolactin production @ ant. pituitary;
 Inc affinity, inc t1/2;
 Tx hyperprolactinemia from pit. adenoma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Somatostatin analog - long acting; Inh insulin, glucagon, GH, and TSH release;
 Short t1/2;
 Tx - insulinomas, glucagonomas, acromegaly, gigantism;
 SE - diarrhea, nausea, abdominal pain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | FSH + LH; Extracted from post-menopausal urine;
 IM admin;
 Tx female infertility
 |  | 
        |  | 
        
        | Term 
 
        | Gonadorelin hydrochloride (Factrel) |  | Definition 
 
        | Synthetic GnRH; SHORT t1/2;
 Diagnostic testing to diff pituitary and hypothalamic lesions in pts w/ hypogonadotropism
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GnRH analog; Inc t1/2, inc receptor binding - induces receptor downregulation;
 Tx prostate cancer, uterine fibroids
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Synthetic ACTH (24 AA); Preferred to natural product b/c no vasopressin activity;
 Use - test integrity of HPA axis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Produced in adrenal cortex (10mg/day); Stimulate gluconeogenesis, glycogenolysis;
 Anti-inflammatory, acts by dec Phospholipase A2, dec cytokines, dec histamine;
 Periphery - [oppose insulin] dec glu use, inc proteolysis, lipolysis;
 Mostly delayed effects;
 90% bound to CBP or albumin;
 Converted (kidney, colon, salivary glands) to cortisone - won't bind MC receptors;
 |  | 
        |  | 
        
        | Term 
 
        | Betamethasone (Celestone) |  | Definition 
 
        | Glucocorticoid; Long t1/2;
 Oral, topical admin;
 Tx asthma
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglutethimide (Cytadren) |  | Definition 
 
        | Adrenocortical "inhibitor"; Inhibits CYP450 - Dec cortisol production;
 Tx Cushings
 |  | 
        |  | 
        
        | Term 
 
        | Ethinyl estradiol (Estinyl) |  | Definition 
 
        | Estrogen - synthetic 17alpha; Dec first pass met;
 Tx CONTRACEPTION (most common Rx)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Synthetic progesterone; Tx endometrial cancer, component of birth control
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SERM; Agonist in bone, brain, liver;
 Antagonist in breast, endometrium;
 Tx breast & endometrial cancers
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SERM; Agonist in bone, brain, liver;
 Antagonist in breast, endometrium;
 Tx breast & endometrial cancers
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-estrogen; Antagonist in all tissues (ER-alpha & -beta);
 Ovulation induction via reflex inc GnRH;
 Tx infertility
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-estrogen; Antagonist in all tissues (ER-alpha & -beta);
 Ovulation induction via reflex inc GnRH;
 Tx infertility
 |  | 
        |  | 
        
        | Term 
 
        | Mifepristone (Mifeprex) - RU 486 |  | Definition 
 
        | Anti-progestin; Blocks P receptor for the termination of gestation in first 7 weeks
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aromatase inhibitor; Block production of estrogens from androgens;
 Tx breast cancer after Tamoxifen fails
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Androgen; [A] Bind androgen receptor - transcriptional regulation;
 [B] Conv to DHT - inc potency;
 [C] Conv to estradiol - closes epiphyseal plates;
 Tx elderly men (inc muscle mass), IM injection for HRT, endometriosis, PMS, anabolic steroids;
 SE - masculinization, virilization, CAD, hepatic carcinoma, suppression of LH & FSH
 |  | 
        |  | 
        
        | Term 
 
        | Methyltestosterone (Oretin methyl) |  | Definition 
 
        | Testosterone derivatve; Oral, short acting;
 [A] Bind androgen receptor - transcriptional regulation;
 [B] Conv to DHT - inc potency;
 [C] Conv to estradiol - closes epiphyseal plates;
 Tx elderly men (inc muscle mass), IM injection for HRT, endometriosis, anabolic steroids;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Testosterone derivatve; IM, long acting;
 [A] Bind androgen receptor - transcriptional regulation;
 [B] Conv to DHT - inc potency;
 [C] Conv to estradiol - closes epiphyseal plates;
 Tx ENDOMETRIOSIS, elderly men (inc muscle mass), IM injection for HRT, endometriosis, PMS, anabolic steroids;
 |  | 
        |  | 
        
        | Term 
 
        | Cyproterone acetate (Cyprostat) |  | Definition 
 
        | Androgen receptor antagonist; Competes with DHT;
 Tx acne, baldness, virilizing syndrome, sexual deviants (dec libido)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Androgen receptor antagonist; Tx prostate cancer;
 SE - hepatotox
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | (also Propecia); Blocks testo conversion (5alpha reductase) to DHT;
 Tx BPH, male-pattern baldness;
 SE - teratogenic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Gen. Sulfonylurea; Oral admin, rapidly absorbed, extensive protein binding;
 Acts @K+ channel;
 Initially inc insulin release;
 Inc insulin sensitivity, inc glu uptake;
 Tx DM, promote hypoglycemia;
 Interaxn w/ NSAIDs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Gen. Sulfonylurea; Oral admin, rapidly absorbed, extensive protein binding;
 Acts @K+ channel;
 Initially inc insulin release;
 Inc insulin sensitivity, inc glu uptake;
 Tx DM, promote hypoglycemia;
 Interaxn w/ NSAIDs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Gen Sulfonylurea - 10-100X more potent; Oral admin, rapidly absorbed, extensive protein binding;
 Acts @K+ channel;
 Initially inc insulin release;
 Inc insulin sensitivity, inc glu uptake;
 Tx DM, promote hypoglycemia;
 Interaxn w/ NSAIDs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Meglitinide - benzoic acid deriv; Very rapid GI absorption;
 Inc insulin secretion;
 Short t1/2, used for post-prandial control
 Tx DM, promote hypoglycemia;
 SE - severe hypoglycemia;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Biguanide; GI absorption - little first pass met.;
 Dec hepatic glucose production;
 No hypoglycemia, NO INSULIN AXN;
 SE - BLACK BOX lactic acidosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Thiazolidindione; GI absorption - little first pass met.;
 Bind PPAR-gamma receptor, inc insulin sensitivity;
 Tx DM, promote hypoglycemia;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-glucosidase (brush border enzyme) inhibitor; Dec carbohydrate (starch) absorption;
 Dec post-prandial glu spike;
 Tx DM, promote hypoglycemia;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Incretin- Works thru GIP/GLP-1 mechanisms, more potent; Synthetic version of exendin-4 (Gila monster);
 Inc insulin, dec glycogenolysis, dec gastric emptying, dec appetite, dec glucagon, some inc in beta cells - hypoglycemia!;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcitriol mimetic; Conv in body to calcitriol;
 Tx - rickets, osteomalacia, hypoparathyroid, osteoporosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcitriol analog; Tx PSORIASIS(better than GCs), rickets, osteomalacia, hypoparathyroid, osteoporosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Gen. Bisphosphonate; Less effective orally;
 Analog of inorganic pyrophosphate;
 Take in morning, without food;
 Inhibits bone resorption;
 Tx - Pagets, osteoporosis, hypercalcemia;
 SE - via IV admin, osteonecrosis of jaw (less common in 1st gen)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Gen. Bisphosphonate - more potent; Most common Rx for post-meno Tx;
 Analog of inorganic pyrophosphate;
 Take in morning, without food;
 Inhibits bone resorption;
 Tx - Pagets, osteoporosis;
 SE - via IV admin, osteonecrosis of jaw (less common in 2nd gen), irritation of esophagus
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 3rd Gen. Bisphosphonate - HIGH POTENCY; Analog of inorganic pyrophosphate;
 Take in morning, without food;
 Inhibits bone resorption;
 Tx - Pagets, osteoporosis, BONE CANCER;
 SE - via IV admin, osteonecrosis of jaw!
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 3rd Gen. Bisphosphonate - HIGH POTENCY; Analog of inorganic pyrophosphate;
 Take in morning, without food;
 Inhibits bone resorption;
 Tx - Pagets, osteoporosis, BONE CANCER;
 SE - via IV admin, osteonecrosis of jaw!
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcimimetic - Ca sensing receptor mimetic; Binds allosterically to the receptor, suppresses PTH;
 Tx hyperparathyroid w/ PT-carcinoma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Protozoal; Activation via enzymatic reduction;
 Blocks pyruvate:ferrodoxone oxidoreductase;
 90% bioavail, BBB penetration, low protein binding;
 Tx - trichomonas, entamoeba h., giardia, anaerobes (B. fragilis, C. diff);
 SE - GI, HA, metallic taste, dizziness, disulfriam-like, anorexia, neuro tox
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Protozoal; Inhibits electron transport, dec pyrimidine synth;
 99% protein bound, lipophillic, hydrophobic;
 Tx pneumocystic pneumonia, toxoplasma, entamoeba, trichomonas, P. falciparum
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Protozoal; Oral (50% bioavail) or IV admin;
 Inh ornithine decarboxylase to block polyamine synth;
 Tx - W. trypanosoma
 SE - anemia, leucopenia, diarrhea, convulsions, GI, alopecia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blood schizontocide; Wide distribution, slow clearance (months);
 Resistance - efflux at P-gp;
 Tx - Plasmodium, non-GI amebiasis;
 Prophylactic use;
 SE - blurred vision (melanin binding, corneal deposits), retina pigmentation, hemolysis (if G6PD deficient);
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blood schizontocide; Block DNA synthesis;
 Tx - P. falci, gametes of P. vivax and P. malariae;
 Poor therapeutic index;
 SE - dec heart contract., dilate vessels, contract uterus, vertigo, hemolysis (if G6PD deficient),
 Cinchonism - tinnitus, blurred vision, HA, dec hearing
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blood schizontocide; Oral admin, 98% bound, excreted in bile;
 Acts only @ asexual erythrocytic stages;
 Block DNA synthesis;
 Tx - P. falci, gametes of P. vivax and P. malariae;
 SE - GI, vertigo, convulsions;
 CI - BBs, chloroquine, quinine, quinidine, hx seizures
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blood schizontocide - Attack plasmodia in red blood cells preventing or terminating the clinical attack; Acts only @ asexual erythrocytic stages;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tissue schizontocide, Gametocidal, Hypnozoitocidal; Rapidly abs and conv to Carboxyprim.;
 Tx - prophylaxis, P. vivax and P. ovale @ hepatic and gamete stages;
 KILLS P. FALCI GAMETES;
 CI - G6PD deficient (X-linked) leads to hemolytic anemia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tissue schizontocide; High abs;
 Inhibits DHFR;
 SE - dec hematopoeisis, megaloblastic anemia;
 Never used alone, oft w/ Sulfadoxine
 |  | 
        |  | 
        
        | Term 
 
        | Fansidar (Sulfadoxine/Pyrimethamine) |  | Definition 
 
        | Tissue schizontocide axn; Tx - chloro-resistant P. falci, Toxoplasma;
 SE - fatal cutaneous rxns (incl erythema multi, SJS, epidermal necrolysis);
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Benzimidazole - Anti-helmintic; Rapid met to albendazole sulfoxide;
 Inh carb transport and microtubule assembly - immobilization and death;
 Blocks larval development;
 Tx helmintics - ascariasis, enterobius, hookworm;
 SE - teratogen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Benzimidazole - Anti-helmintic; Poor abs, highly bound;
 Inh carb transport and microtubule assembly - immobilization and death;
 Blocks larval development;
 Tx helmintics - ascariasis, enterobius (pin), Trichuris (whip), hookworm;
 SE - teratogen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-helmintic; Inc Ca++ perm - spastic paralysis;
 Readily abs, hi first pass met, inc metabolites;
 Tx - tapeworms, schistosomiasis, 3 forms of fluke;
 SE - GI, HA;
 CI - Carbamazepine & Phenobarbital dec bioavail; Cimetidine inc bioavail, ocular schistosomiasis;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-helmintic; Oral admin, no met, long t1/2 (slow cl);
 Inc Cl perm. - inh glutamate and GABA-ergic channels - paralysis;
 Tx - strongyloidiasis, onchocerca (rvr blindness);
 SE - GI, itch, dizzy, inflamm rxn to dying bugs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-helmintic; Rapid GI abs;
 Tx lymphatic filariasis;
 SE - anorexia, nausea, HA
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-helmintic; Poor abs;
 Bind N receptors - depol blockade - spastic paralysis (bug falls off GI wall);
 Tx - MONILIFORMIS, GI nematodes;
 Dec SE due to localization of drug in GI - HA, dizziness, rash
 |  | 
        |  | 
        
        | Term 
 
        | Cholestyramine (Questran) |  | Definition 
 
        | Bile acid sequesterants; Powder form;
 Anionic, binds (-) bile acids in GI - inh bile recycling - liver excretes more chol;
 Safe for children, hepatic dz;
 Dec LDL by 25%;
 SE - sandy texture, flatulence, hypertriglyceridemia, constipation, drug interaction;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statin - inh HMG-CoA Reductase; Prodrug, intestinal reabsorb by P-gp;
 Inh chol. synthesis in liver - inc # of LDL receptors - clearance of VLDL and LDL from blood;
 Dec LDL by 60%;
 SE - GI, sleep disrup, teratogenic, rhabdomyolysis, myositis, myalgia, inc aminotransferases, INTERAXN @ CYP3A4;
 CI - renal dz
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statin - inh HMG-CoA Reductase; Inc potency, dec renal cl, intestinal reabsorb by P-gp;
 Inh chol. synthesis in liver - inc # of LDL receptors - clearance of VLDL and LDL from blood;
 Dec LDL by 60%;
 SE - GI, sleep disrup, teratogenic, rhabdomyolysis, myositis, myalgia, inc aminotransferases, INTERAXN @ CYP3A4;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholesterol absorption inhibitor; Blocks internalization of NPC1L1 - dec chol abs by 50% - dec hepatic chol - upreg of LDL receptors - dec LDL by 18%;
 SE - GI, fatuge, gallstones, Category C, inc liver enzymes;
 Inc lvls in elderly, female;
 CI - <10y.o., hepatic or renal insuff, lactation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fibrate - anti-lipid; Active met - fenofibric acid - glucaronidation;
 Activate PPAR-alpha - FA oxidation, inc biliary chol excretion (Dec TG by 50%);
 Inc HDL (Apo-A1), no effect on LDL!;
 SE - gallstones, inc transaminases, dec GFR, azotemia;
 CI - renal dz
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-lipid; Dec FFA mobilization - dec TG & ApoB synth (dec VLDL), inc HDL transport, enhanced LPL;
 Dec LDL by 25%, Dec TG by 50%, Dec Lp(a);
 Dec CHD/MI incidence;
 SE - hepatotox (inc enzymes), flushing, conjunctivitis, retinal detach, inc insulin resistance (a. nigricans), gout, dry skin, Category C, pruritis
 |  | 
        |  | 
        
        | Term 
 
        | Levothyroxine (Synthroid) |  | Definition 
 
        | L-T4; Most common Rx;
 Calorigenic, inc HR, cardiac contraction force
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | L-T4 and L-T3; Calorigenic, inc HR, cardiac contraction force
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Thioureylenes - anti-thyroid; [1] Inh I organification (via peroxidases), can't bind to thyroglobulin;
 [2] Inh periph. (liver) conversion of T4->T3;
 Tx hyperthyroidism;
 SE - agranulocytosis, rash;
 Less likely to cross placenta, use caution
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Thioureylenes - anti-thyroid; Inh I organification(via peroxidases), can't bind to thyroglobulin;
 10X more potent and longer t1/2 than PTU;
 Tx - hyperthyroidism
 SE - teratogen
 |  | 
        |  | 
        
        | Term 
 
        | Radioactive iodine, Na-131I |  | Definition 
 
        | Oral admin; In thyroid, beta-radiation will destroy parenchymal cells, minimum collateral dmg;
 Adult usage, but not in women of child-bearing age;
 Tx enlarged thyroid (Graves, goiter)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inh periph (liver, kidney, pituitary, brain) conv of T4->T3; Tx hyperthyroidism (off-label)
 |  | 
        |  | 
        
        | Term 
 
        | Marijuana (Cannabis sativa)
 |  | Definition 
 
        | Delta-9-THC psychoactive compound; cannabinol (CBN) less active metabolite, cannabidiol (CBD) anxiolytic;
 Retrograde transmission - inc extracellular K, block Ca++ influx, ↓NT release, dec cAMP leads  to tolerance;
 SE - psychotoxicity, carcinogenic (SCC), teratogenic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acute - ↓memory, confusion, depersonalization, ↑ hunger, ↓REM, ↓ balance, dry mouth EARLY High:Euphoria, laughter time distortion
 LATE: relaxation, introspection, dream like state
 Chronic - amotivational syndrome, apathy, dullness, ↓concentration, ↓memory
 Tolerance:↓adenylate cyclase (cAMP), ↓receptors (CB1, CB2) cross tolerance with opiods and EtOH
 |  | 
        |  | 
        
        | Term 
 
        | Cardiovascular effects of Marijuana |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Immune effects of Marijuana |  | Definition 
 
        | ↓ T-cells; suppress immune response Via CB2 receptor on lymphocytes and macrophages
 |  | 
        |  | 
        
        | Term 
 
        | Endocrine effects of Marijuana |  | Definition 
 
        | ↓ LH and FSH - ↓ testosterone, testes♂, ↓ libido; ↓GH, ↓ Prl, ↑ACTH;
 Anovulatory cycles♀
 |  | 
        |  | 
        
        | Term 
 
        | Respiratory effects of Marijuana |  | Definition 
 
        | Acute - bronchodilates; Chronic - bronchoconstricts
 |  | 
        |  | 
        
        | Term 
 
        | Withdrawl effects of Marijuana |  | Definition 
 
        | Irritable, Nausea,
 Insomnia,
 Sweating,
 Anorexia,
 Hand tremor,
 Restlessness
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Medical marijuana; NATURAL product extracted THC Approved Use: Antiemetic during chemo, AIDS wasting syndrome;
 Possible - MS, spinal injury, Tourette's, dyskinesias
 |  | 
        |  | 
        
        | Term 
 
        | LSD (lysergic acid Diethylamide
 |  | Definition 
 
        | 5-HT2 partial agonist; Physio - sympathomimetic;
 Psychic - visual hallucinations, time/sense alter, loss of boundaries, emergence of thoughts/memories, 'magically in control', synesthesia
 SE-Bad trip, persistent rx with BNZ, sober flashbacks
 |  | 
        |  | 
        
        | Term 
 
        | Mescaline 3,4,5-trimethoxyphenethylamine
 |  | Definition 
 
        | Psychedelic alkaloid, 5HT and DA agonist; Physio - Sympathomimetic;
 Psychic - hallucinations, unusual time perception;
 SE - paranoia and fear
 Schedule 1 drug
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cactus known for containing Mescaline Peyote Buttons
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PCP, Angel Dust; NMDA receptor antagonist, Sigma receptor agonist, Dopamine/NE reuptake inhibitor;
 Physio - sympathomimetic;
 Psychic - Inc sensitivity to stimuli, dec proprioception, restlessness, mood elevation, disorientation, detachment, anxiety, perceptual disturbance, detachment;
 Tox - hostility, confusion, coma, schizo, behavorial
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 24% abs @ 6 mos 18% abs @ 1 yr
 Terminate use after 6 mo.;
 Best efficacy in combination with cessation programs and pharmacologic aids  e.g. zyban
 Must retain in mouth for 2-30 minutes
 CI - oral lesions, active smoking
 |  | 
        |  | 
        
        | Term 
 
        | Nicotine Patch (Habitrol) |  | Definition 
 
        | Transdermal patch, variable time to peak plasma concentration, Prostep the longest with peak at 9 hrs 16.8% abs @ 6 mos;
 Well tolerated;
 Best efficacy in combination with cessation programs;
 SE - sleep disturbance, skin irritation;
 CI - active smoking additive
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nicotine receptor partial agonist, non-nicotine cessation aid; High affinity @ alpha4-beta2-cont. receptors; some affinity @ 5HT-3;
 25% @ 12 mos rmain quit, 2nd line tx after Buproprion
 SE: BB warning suicidal ideation, nausea
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-nicotine cessation aid; Anti-HTN medication Non-selective antagonist a non-alpha7-N cholinergic receptors;
 Crosses BBB;
 Action @ brain and peripheral ganglia - ↑ SE's;
 Inconclusive efficacy, use w/ patch;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NMDA antagonist, alters ion channels – initial excitatory then depressive; diff channels effected at diff concentrations of intox;
 Detox req ADH and ALDH enzymes;
 Women - dec gastric first pass met and ↓ ADH levels;
 SE - CNS dmg, hepatomegaly, vasodilation, cardiomyopathy, pancreatitis, anemia, bone marrow suppression, teratogenic;
 CI – NSAIDs
 |  | 
        |  | 
        
        | Term 
 
        | Ethanol CNS damage, mechanisms |  | Definition 
 
        | Thiamine B1 deficiency - beriberi; Wernicke's encephalopathy - nystagmus, ocular palsies, ataxia, gait;
 Korsakoff's psychosis - confabulation; antero and retrograde amnesia
 Cerebellar degen - ataxia;
 Pontine myelinolysis - dysarthria, confusion;
 Marchiafava-Bignami - apathy, Alz-like dementia, movement disorders;
 Pellagra-Niacin B3 deficiency – 5 Ds (incl dementia, diarrhea and  dermatitis)
 Hepatic encephalopathy (ammonia increase)
 Peripheral neuropathies
 Direct CNS toxicity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Early: agitation, confusion, hyperactive ANS, seizure(2-48hrs) Late: Delirium Tremons- hyperthermia, hallucination, disorientation;
 Coma, death
 Trx: BNZ, phenytoin, Phenobarbital (siezures) atenolol, clonidine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Wood alcohol; Oxidized to form FORMALDEHYDE(!) and formic ACID
 SE - blindness, irreversible acidosis, death;
 Tx OD w/ ethanol (competitive substrate) and dialysis, treat acidosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Vitamin B1 Should admin to all alcoholics in distress;
 Replacement for thiamine lost in deficient state
 Deficiency is Beriberi Wet=CV complications Dry=CNS complications, B1 involved in glucose metabolism , lethargy, neuropathy, GI complications and arrythmias
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ALDH antagonist - ↑acetaldehyde; Inhibits DA beta-hydroxylase (↓ NE);
 Acetaldehyde syndrome - ↑HR, flush, hypotension, N/V, HA;
 NO effect on cravings
 Tx - chronic alcoholism;
 SE - hepatotoxcity, depression, psychosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Opioid receptor antagonist; LONG DURATION (24 hrs) effect t1/2=4 hrs
 oral admin, extensive first pass;
 tx alcohol abuse (↓craving and ↓ relapse);
 ↓ number of 'heavy drinking days'
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-emetic - 5-HT3 antagonist; Dec craving by blocking the reward pathway;
 Tx - chronic alcoholism;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | AMPA-R antagonist, GABA-R regulator; Tx - chronic alcoholism;
 Dec 'heavy drinking days';
 Need to titrate dosing;
 SE – glaucoma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tx EtOH withdrawal stages... tremulousness syndrome,
 DT
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral or IV; Tx Acetaminophen OD when >[150mg/mL] @ 4hrs OR >[75mg/mL] @ 8 hrs;
 Use in first 10 hrs;
 SE - anaphylaxis, N/V, taste/odor;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Benzodiazepine antagonist; Tx BNZ OD;
 Can produce withdrawal symptoms, not used too often;
 SE - N/V, dizzy, panic attacks, seizures, blurred vision
 |  | 
        |  | 
        
        | Term 
 
        | Physostigmine (Antilirium) |  | Definition 
 
        | reversible anticholinesterase; tx atropine O.D., other anticholinergic (antidepressant, antihistamine, antiemetic, antipsychotics) OD
 crosses BBB, CNS stim then depression;
 CI - TCA's
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tx organophoshate (insecticide) OD; Use with supportive tx
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | reactivator of cholinesterase; Slow IV admin;
 Tx organophosphate, sarin, soman OD!;
 Rapid admin SE's - NM block, msucle spasm, HTN, tachycardia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Chelator used in OD Tx of lead (mild cases, approved for children), arsenic, and mercury (inc mercury excretion in vapor exposure); Reduces blood lvls, can't repair damage;
 SE - hypersensitivity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Chelator; First line tx for arsenic poisoning;
 Also Tx lead, mercury poisoning;
 SE - nephrotoxic;
 CI - G6PD deficiency
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Iron chelator; Tx - first line for iron tox;
 SE - red urine, tachycardia, hypoT, abdominal pain, N/V, flush, fever
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | TCA (tertiary amine); Inhibits reuptake of NE and 5-HT at presynaptic terminals = potentiation;
 VERY SEDATING, ANTICHOLINERGIC;
 Blocks mAch, 5-HT, and histamine receptors;
 Tx - depression, anxiety, ADHD, nocturnal enuresis;
 High lipid solubility;
 Low therapeutic index;
 SE - orthostatic hypoT, tachycardia, confusion, anticholinergics, worsen narrow-angle glaucoma and CHF, acidosis, delirium, seizures;
 CI: Additive CNS depression (EtOH, hypnotics)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | TCA (tertiary amine); Inhibits reuptake of NE and 5-HT at presynaptic terminals = potentiation;
 Blocks mAch, 5-HT, and histamine receptors;
 Tx - depression, anxiety, ADHD, nocturnal enuresis;
 High lipid solubility;
 low therapeutic index;
 CYP2D6, conjugation
 SE - orthostatic hypoT, tachycardia, confusion, anticholinergics, worsen narrow-angle glaucoma and CHF, acidosis, delerium, seizures;
 CI: Additive CNS depression (EtOH, hypnotics) ↓effect of anti-HTN clonidine, methyl-DOPA and guanethidine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | TCA (secondary amine); Inhibits reuptake of NE and 5-HT at presynaptic terminals = potentiation;
 LITTLE sedation;
 Blocks mAch, NO 5-HT EFFECT, and little histamine receptors;
 Tx - depression, anxiety, ADHD, nocturnal enuresis;
 High lipid solubility;
 Low therapeutic index;
 SE - orthostatic hypoT, tachycardia, confusion, anticholinergics, worsen narrow-angle glaucoma and CHF, acidosis, delerium, seizures;
 CI: Additive CNS depression (EtOH, hypnotics)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Atypical antidepressant; 2nd Generation NO sedation NO anticholinergic;
 MOA uncertain, blocks NE reuptake, weak blocker of DAT, SERT, NET;
 SE - anxiety, restlessness, seizure;
 Can be used in smoking cessation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Atypical antidepressant - 3rd generation; STRONG SEDATION;
 Antagonizes presynaptic α-2 receptors [unique] - ↑ release of serotonin and NE; NOT MDR-1 substrate;
 Antagonizes 5-HT2 receptors, Anti-histamine action;
 SE - sedation, weight gain;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Atypical antidepressant - 3rd Generation; POTENT anticholinergic
 5-HT reuptake inhibitor, NO NE effect;
 INHIIBITS CYP3A4;
 Tx depression w/ sleep disturbance and/or anxiety;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SSRI - inhibits SERT to potentiate serotonin action; CNS stimulation, euphoria;
 Tx -  MDD, panic attack, OCD, ADHD ….
 Long t1/2 - 3 days;
 High therapeutic index;
 SE - nausea, dec libido;
 LEAST side effects of SSRIs;
 CI - MAOI, amphetamines, ecstasy, LSD, L-tryptophan;
 Serotonin syndrome!
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SSRI - inhibits SERT to potentiate serotonin action; CNS stimulation, euphoria;
 Long t1/2 - a WEEK!;
 High therapeutic index;
 NOT MDR-1 substrate;
 SE - nausea, dec libido;
 CI - MAOI, amphetamines, ecstasy, LSD, L-tryptophan;
 Serotonin syndrome!
 MAY ↑levels of lithium, warfarin and TCA
 |  | 
        |  | 
        
        | Term 
 
        | Tranylcypromine (Parnate) |  | Definition 
 
        | MAOI - 2nd line anti-depressants; also Tx - panic disorder, agoraphobia;
 Irreversibly inhibits oxidative metabolism of monoamines (NE, 5-HT) ↑ stores in vesicles and released;
 Acute: CNS Stimulation, agitation euphoria possible
 Requires daily dosing due to inactivation;
 SE - orthostatic hypoT sleep disturbance, agitation;
 CI - cheeses (tyramine) EtOH, Beer, sympathomimetics [Acute HTN], Meperidine, dextromethorpham, SSRIs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAOI - 2nd line anti-depressants; also Tx - panic disorder, agoraphobia;
 Irreversibly inhibits oxidative metabolism of monoamines (NE, 5-HT) ↑ stores in vesicles and released;
 Acute: CNS Stimulation, agitation euphoria possible
 Requires daily dosing due to inactivation;
 SE - orthostatic hypoT sleep disturbance, agitation;
 CI - cheeses (tyramine) EtOH, Beer, sympathomimetics [Acute HTN], Meperidine, dextromethorpham, SSRIs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAOI - 2nd line anti-depressants; also Tx - panic disorder, agoraphobia;
 Irreversibly inhibits oxidative metabolism of monoamines (NE, 5-HT) ↑ stores in vesicles and released;
 Acute: CNS Stimulation, agitation euphoria possible
 Requires daily dosing due to inactivation;
 SE - orthostatic hypoT sleep disturbance, agitation;
 CI - cheeses (tyramine) EtOH, Beer, sympathomimetics [Acute HTN], Meperidine, dextromethorpham, SSRIs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mood-stabilizer; First line in treating Bipolar;
 Unknown MOA - may block inositol P signal and AC activity;
 Rapid absorption, NOT metabolized, renal clearance - t1/2 = 20 hrs;
 NARROW THERAPEUTIC WINDOW;
 SE - tremor, ataxia, hyperactive, aphasia, sedation, edema, hypothyroid, nephrogenic DI, cardiac sick sinus syndrome [bradycardia], acne, folliculitis, ↑psoriasis;
 CI: NSAIDS alter renal elimination
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | BRA - approved for insomnia; Modify the response of GABA receptor to GABA (shift dose response curve left);
 Require GABA;
 Specific for BZ-1 receptor at approved doses;
 Pregnancy category C (Okay, but caution), schedule IV;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | BRA - approved for insomnia; Modify the response of GABA receptor to GABA (shift dose response curve left);
 Require GABA;
 Specific for BZ-1 receptor at approved doses;
 Pregnancy category C (Okay, but caution), schedule IV;
 ETHNIC VARIABILITY - Asians, must ↓ the dose ALDH
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HIV Fusion Inhibitor - by binding gp41 of viral envelope; Admin SQ, 2X a day;
 Met by proteolytic hydrolysis, no CYP rxns;
 No cross resistance with OTHER drugs;
 Only for tx-experienced pts;
 SE - inc risk of bacterial pneumonia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nucleoside Reverse Transcriptase Inh (NRTI) - Anti-retroviral; Nucleoside analog (pyrimidine-T) acts as competitive inhibitor - block elongation in previously uninfected cells;
 Req (+P)X3 for axn;
 Dec perinatal HIV transmission;
 Met by glucaronidation;
 Avoid fatty meals (dec AUC);
 SE - MYELOSUPPRESSION, lactic acidosis, lipodystrophy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nucleoside Reverse Transcriptase Inh (NRTI) - Anti-retroviral; Nucleoside analog (purine-A,G) forms active ddATP - act as competitive inhibitor - block elongation in previously uninfected cells;
 Req (+P)X3 for axn;
 Don't take w/ acidic foods (dec AUC);
 SE - PERIPHERAL NEUROPATHY, PANCREATITIS, lactic acidosis, lipodystrophy, many drug interaxns
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nucleoside Reverse Transcriptase Inh (NRTI) - Anti-retroviral, Anti-HBV; Nucleoside analog (pyrimidine-C) acts as competitive inhibitor - block elongation in previously uninfected cells;
 Req (+P)X3 for axn;
 Longest NRTI t1/2;
 SE - lactic acidosis, lipodystrophy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Protease inhibitor - Anti-retroviral; Most eff. ART - competitive, reversible, inh of protease binding site, esp in monocytes, macrophages - blocks MATURATION;
 CYP3A4 INHIBITION - but least in class;
 LARGE AUC if taken w/ meals;
 SE - hyperlipid, DM, lipodystrophy, inc liver enzymes, inc bleeding in hemophliacs;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Protease inhibitor - Anti-retroviral; Most eff. ART - competitive, reversible, inh of protease binding site, esp in monocytes, macrophages - blocks MATURATION;
 CYP3A4 INHIBITION - most potent;
 SE - HEPATOTOX, hyperlipid, DM, lipodystrophy, inc liver enzymes, inc bleeding in hemophliacs;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Herpes - Nucleoside analog; Inh viral DNA pol - chain termination;
 Purine analog;
 Tx - HSV, VZV, CMV;
 Req (+P) by VIRAL thymidine kinase;
 SE - HA, nausea, diarrhea, renal, CNS: tremors, delirium, seizures;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Herpes - Nucleoside analog; Inh viral DNA pol - chain termination;
 Acyclovir prodrug - Purine analog;
 Tx - HSV, VZV, CMV;
 Req (+P) by VIRAL thymidine kinase;
 SE - HA, nausea, diarrhea, renal, CNS: tremors, delirium, seizures;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Herpes - Nucleoside analog; Inh viral DNA pol - COMPETITIVE INH, NO chain termination;
 Penciclovir prodrug - guanine analog;
 Tx - HSV, VZV, CMV, also HBV;
 Req (+P) by VIRAL thymidine kinase;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Herpes - Nucleoside analog; Inh viral DNA pol - chain termination;
 Tx - CMV DOC, CMV RETINITIS;
 Req (+P) by VIRAL thymidine kinase;
 100X more potent than Acyclovir;
 SE - MYELOSUPP., TERATOGENIC, HA, nausea, diarrhea;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Herpes - NucleoTIDE analog; No (+P) by viral TK;
 Tx - HSV, VZV, CMV RETINITIS;
 SE - NEPHROTOX, neutropenia, carcinogenic, ocular hypotony
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pyrophosphate analog - Anti-Herpes; "Non-nucleoside";
 Inh DNA pol by blocking cleavage, ALSO Inh HIV-RT;
 NO (+P) required;
 Tx - nucleoside resistant cases (HSV, VZV, CMV), CMV retinitis;
 SE - NEPHROTOX, N/V, anemia, fatigue
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-hep - nucleoside analog (G); Competitive inh of GTP 5' capping of viral mRNA;
 Concentrates in RBCs;
 Tx - HCV, RSV;
 SE - hemolytic anemia, teratogenic, myelosupp.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Parkinsonism, Anti-flu - Uncoating inh; Blocks HA glycoprotein maturation - blocks binding to M2 ion channel;
 No internal acidification;
 Work on Flu-A ONLY;
 Enhances DA release;
 "Good alternative to flu vaccine";
 SE - restless, depression, psychosis, hallucinations, confusion;
 CI - seizures, heart failure
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-flu - Viral Release Inh; Inh viral neuraminidase - no cleavage of sialic acid - destroys receptors recognized by HA - no detachment from host cell;
 Admin via inhalation (low PO bioavail);
 Tx flu-A(2nd line) and B
 |  | 
        |  | 
        
        | Term 
 
        | Chloropromazine (Thorazine) |  | Definition 
 
        | Typical Anti-Psychotic - low potency; Inh of D2 receptor - effective for positive symptoms;
 Aliphatic side chain - low potency (dec risk of EPS, inc risk of anti-muscarinic effects);
 Tx for Huntington's chorea(DA antagonism;
 SE - corneal deposits, INC PRL (severe), DEC INSULIN, JAUNDICE, ANTI-DIURETIC, ORTHOSTATIC hypoT, skin rxns, EPS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Typical Anti-Psychotic; Inh of D2 receptor - effective for positive symptoms;
 Piperdine ring;
 Dec incidence of EPS;
 SE - inc PRL, highly anti-muscarinic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Typical Anti-Psychotic - hi potency; Inh of D2 receptor - effective for positive symptoms;
 Tx for Huntington's chorea(DA antagonism);
 SE - EPS, inc PRL
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Atypical Anti-Psychotic; D2 and 5-HT2 (high affinity) antagonism;
 Inc efficacy for Negative symptoms (as well as positives);
 Limited EPS;
 SE - BLOOD DYSCRASIAS (esp leukopenia), inc risk of DM typeII, WEIGHT GAIN;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Atypical Anti-Psychotic; D2 and 5-HT2 (high affinity) antagonism;
 Inc efficacy for Negative symptoms (as well as positives);
 Tx CHILDREN AND TEENS;
 Limited EPS;
 SE - inc PRL, inc risk of DM typeII, METABOLIC SYNDROME;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Atypical Anti-Psychotic; D2 and 5-HT2 (high affinity) antagonism;
 Inc efficacy for Negative symptoms (as well as positives);
 SE - WEIGHT GAIN, METABOLIC SYNDROME (hi incidence), inc risk of DM typeII;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Atypical Anti-Psychotic; D2 and 5-HT2 (high affinity) antagonism;
 Inc efficacy for Negative symptoms (as well as positives);
 No effect on PRL levels;
 SE - METABOLIC SYNDROME, inc risk of DM typeII;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Atypical Anti-Psychotic; D2 and 5-HT2A,1A,2C (high affinity) antagonism;
 Inc efficacy for Negative symptoms (as well as positives);
 Limited EPS;
 SE - inc risk of DM typeII;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Atypical Anti-Psychotic; D2 partial agonist, 5-HT2 antagonist, and 5-HT1A partial agonist;
 Inc efficacy for Negative symptoms (as well as positives);
 No effect on PRL levels;
 SE - inc risk of DM typeII;
 |  | 
        |  | 
        
        | Term 
 
        | CNS effects of Anti-Psychotics (6 sites) |  | Definition 
 
        | Cortex - dec seizure threshold; Basal ganglia - inc DA metabolism, inc Ach turnover;
 Limbic - main site of anti-psychotic efx;
 Hypothalamus - inc PRL;
 Brainstem - dec reflexes;
 CTZ - protect AGAINST N/V
 |  | 
        |  | 
        
        | Term 
 
        | Endocrine effects of Anti-Psychotics |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cardiovascular effects of Anti-Psychotics |  | Definition 
 
        | Direct and indirect effects; Orthostatic hypotension - esp chlorpromazine
 |  | 
        |  | 
        
        | Term 
 
        | EPS of of Anti-Psychotics (6) |  | Definition 
 
        | Acute dystonia; Akathesia;
 Parkinsonian syndrome;
 Neuroleptic Malignant Syndrome;
 Perioral tremor;
 Tardive dyskinesia
 |  | 
        |  | 
        
        | Term 
 
        | Anti-cholinergic effects of Anti-Psychotics |  | Definition 
 
        | Dry mouth; blurred vision;
 constipation;
 nasal congestion;
 orthostatic hypoT
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Parkinsonism Tx; Allowed to cross BBB and Conv to DA by endogenous L-AAD @CNS AND peripherally (large dose req'd);
 First line for Park. but can only use 3-5 years;
 SE - anorexia, orthostatic hypoT, arrhythmias (Afib), tachycardia;
 CI - Vit B6, MAOI, glaucoma, psychosis, ulcers CV dz
 |  | 
        |  | 
        
        | Term 
 
        | L-DOPA/carbidopa (Sinemet) |  | Definition 
 
        | Parkinsonism Tx; L-DOPA fxn PLUS...
 Peripheral inh of L-AAD - dec amt of L-DOPA req for therapy;
 Fluctuating responses;
 SE - depression, anxiety, delusions, chorea, tics;
 CI - Vit B6, MAOI, glaucoma, psychosis, ulcers CV dz
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Parkinsonism Tx - DA receptor agonist; Activate D2 - dec activation of indirect basal ganglia pathways;
 D2 agonist, D1 partial agonist;
 Tx EARLY dz
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Parkinsonism Tx - DA receptor agonist; Activate D2 - dec activation of indirect basal ganglia pathways;
 D1/D2 agonist, inc efficacy;
 Tx EARLY dz
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Parkinsonism Tx - DA receptor agonist; Activate D2 - dec activation of indirect basal ganglia pathways;
 D2 selective agonist;
 Tx EARLY dz
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Parkinsonism Tx - COMT inhibitor; Prolong axn of L-DOPA and dec it's transport-competitor 3OMD;
 PERIPHERAL AXN;
 Preferred due to dec SE's
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Parkinsonism Tx - Anti-muscarinic; Alter DA/Ach balance by blocking Ach-stimulation of striatum;
 Tx early Park or as adjunct to L-DOPA;
 SE - drowsy, inattention, delusions, hallucinations, typical ANS anti-Ach axns
 |  | 
        |  | 
        
        | Term 
 
        | Diphenhydramine (Benadryl) |  | Definition 
 
        | Parkinsonism Tx - Anti-muscarinic; Alter DA/Ach balance by blocking Ach-stimulation of striatum;
 Tx early Park or as adjunct to L-DOPA;
 SE - drowsy, inattention, delusions, hallucinations, typical ANS anti-Ach axns
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alzheimer's Dz Tx - Ach-esterase Inh; Inc lvls of Ach;
 Long t1/2 - 70hrs;
 SE - GI, insomnia, bradycardia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alzheimer's Dz Tx - Ach-esterase Inh; Inc lvls of Ach;
 SE - GI, insomnia, bradycardia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ALS tx; Dec Glu release by (1) block inactive Na-channel, (2) block activated Ca-channel;
 Also (3) block NMDA channel;
 Met by CYP1A2;
 Hi protein binding;
 SE - fatigue, sedation, liver dz
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MS tx - Anti-inflamm; Restores BBB - dec immune response in CNS;
 More effective than interferon;
 Tx also Crohn's;
 SE - PML!! (progressive multifocal leukoencephalopathy)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Epilepsy - Hydantoin; Stabilizes inactive Na channels;
 Met by CYP2C4, induces 2C and 3A;
 Highly protein bound - competes w/ other drugs (warfarin, OCT, carbamazepine);
 SE - [narrow TI] nystagmus, ataxia, arrhythmias, coarsened face, hirsutism, gingival hyperplasia, peripheral neuropathy, bone disruption, teratogenic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-epilepsy - barbiturate; Prolong opening of GABA receptor;
 Blocks AMPA receptor;
 Induce CYP2b6 and UGT;
 SE - sedation, lethargy, nystagmus, rash, megaloblastic anemia, dec vitD
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-epilepsy - iminostilbenes; Mood-stabilizer;
 Prolongs Na channel recovery;
 Met by CYP2C9,3A4 to active 10,11-epoxide;
 Induces CYP1A2, 2B6, 2C19, UGT;
 Tx - DOC for partial seizures, T/C, mood stabilizer for bipolar, trigeminal neuralgia;
 Tx depression typically assoc w/ Huntington's;
 SE - blood dyscrasias, diplopia, ataxia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-epilepsy - succinimides; Inh of T-type Ca channels - prevents 3Hz spike/waves;
 Inc AUC when given w/ valproic acid;
 Met by hydroxylation;
 Tx - DOC for absence seizures;
 SE - [tolerance] euphoria, hiccups, fatigue
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-epileptics - Carboxyllic acid; Stabalizes inactive Na channels, Dec Ca current, stimulates GABA synth and inhibits degradation;
 Met by UGT via beta-ox - also inhibits it;
 Inh CYP2C9;
 Tx - absence + T/C DOC, myoclonic, partial;
 Inc [plasma] phenobarb, phenytoin, carbamazepine;
 SE - heartburn, liver tox, teratogenic;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-epilepsy - BNZ; Inc opening of GABA Cl channel;
 Can be given rectally;
 Tx - refractory myoclonic, atonic, absence;
 SE - sedation, lethargy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-epilepsy - BNZ; Inc opening of GABA Cl channel;
 Tx - DOC status epilepticus;
 SE - sedation, lethargy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-epilepsy - BNZ; Inc opening of GABA Cl channel;
 Long acting, can admin rectally;
 Tx - status epilepticus;
 SE - sedation, lethargy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-epileptic; Inh Na channels, inh T-type Ca channels;
 Tx - parital seizures, infantile spasm, myoclonic, generalized and absence;
 Met by CYP3A4;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscle Relaxant; GABA(B) agonist - inhibitory and hyperpolarization;
 Inh substance P;
 Admin oral or intrathecal;
 Don't d/c abruptly - rebound neural hyperactivity;
 Tx - spasticity, MS;
 SE - sedation, CNS depression, hypoT
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscle Relaxant; Pre-synaptic alpha2 agonist - dec axn of spinal motor neurons;
 Admin oral - hi first pass met.;
 Tx - spasticity, MS;
 SE - SEDATION, hepatotox, anticholinergics, hypoT;
 CI with other drugs acting on alpha2;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscle Relaxant; Blocks ryanodine receptor - confine Ca in sarcoplasmic reticulum - dec SKELETAL muscle axn;
 Admin oral or IV - hepatic met (perform liver fxn tests);
 Tx - spasticity, malignant hyperthermia, neuroleptic malignant syndrome;
 SE - phlebitis, heptotox w/ estrogen, CNS depression, floppy child syndrome
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscle Relaxant; CNS axn to sedate and dec pain, no direct efx on conduction;
 Met by CYP2C19;
 Tx - spasm;
 SE - sedation, insomnia, vertigo, ataxia, vision loss, mydriasis, orthostatic hypoT
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscle Relaxant-ish; GABA analog that binds to alpha-2-delta to inh neuronal Ca channels;
 Dec neuropathic pain;
 Tx - FIBROMYALGIA (muscle/joint pain);
 SE - sedation, blurred vision, weight gain, swelling, xerostomia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - cell wall synth - B-lactam - "Natural Pen"; Block cell wall-synth enzymes;
 Oral admin;
 Glomerular filtration, secretion;
 Tx - G+ (staph, strep), GC, spirochetes (T. pallidum);
 Res - B-lactamase (staph);
 SE - rash, neurotoxic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - cell wall synth - B-lactam; Block cell wall-synth enzymes;
 Parenteral admin;
 Glomerular filtration, secretion;
 SE - rash, neurotoxic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - cell wall synth - B-lactam - "Anti-staph"; Block cell wall-synth enzymes;
 Parenteral admin;
 Glomerular filtration, secretion;
 Highly protein bound, acid stable;
 Tx B-lactamase-producing staph;
 SE - DEC ELECTROLYTES, rash, neurotoxic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - cell wall synth - B-lactam - "Extended spectrum"; Block cell wall-synth enzymes;
 Parenteral or oral admin;
 Glomerular filtration, secretion;
 Req supplement after dialysis;
 Tx - [G+ and G- rods/bacilli] H. flu, E. coli;
 Res - B-lactamase (G-);
 SE - DELAYED RASH, DIARRHEA, PSEUDOMEMBRANOUS COLITIS, neurotoxic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - cell wall synth - B-lactam - "Extended spectrum"; Block cell wall-synth enzymes;
 Oral admin;
 Glomerular filtration, secretion;
 Req supplement after dialysis;
 Tx - [G+ and G- rods/bacilli] H. flu, E. coli;
 Res - B-lactamase (G-);
 SE - DELAYED RASH, PSEUDOMEMBRANOUS COLITIS, neurotoxic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - cell wall synth - B-lactam - 1st Gen Cephalosporin; Renal tubular secretion - inc [plasma] w/ probenecid;
 Tx - G+ cocci, many G- bacilli (think ampicillin);
 SE - hypersensitivity, phlebitis, IM pain, nephrotoxic, rare superinfections;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - cell wall synth - B-lactam - 2nd Gen Cephalosporin; Renal tubular secretion - inc [plasma] w/ probenecid;
 Tx - H. flu, B. fragilis;
 SE - hypersensitivity, phlebitis, IM pain, nephrotoxic, rare superinfections;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - cell wall synth - B-lactam - 3rd Gen Cephalosporin; Renal tubular secretion - inc [plasma] w/ probenecid;
 HIGHLY MET'D;
 CROSSES BBB TO CSF;
 Tx - [severe] enteric G-'s, B. fragilis, H. flu, Pseudo.;
 SE - ENTEROBACTER SUPERINFECTIONS, hypersensitivity, phlebitis, IM pain, nephrotoxic;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - cell wall synth - B-lactam - 3rd Gen Cephalosporin; Renal tubular secretion - inc [plasma] w/ probenecid;
 LONGEST T1/2, HIGHLY PROTEIN BOUND - Dialysis OK;
 CROSSES BBB TO CSF;
 Tx - [severe] enteric G-'s, B. fragilis, H. flu, Pseudo.;
 SE - ENTEROBACTER SUPERINFECTIONS, hypersensitivity, phlebitis, IM pain, nephrotoxic;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - cell wall synth - B-lactam - 4th Gen Cephalosporin; Renal tubular secretion - inc [plasma] w/ probenecid;
 BROAD SPECTRUM - incl G+ w/ B-lactamase;
 Tx - Pseudo, Klebsiella, E.coli;
 SE - hypersensitivity, phlebitis, IM pain, nephrotoxic, rare superinfections;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - cell wall synth; Cidal effects w/ narrow spectrum;
 Oral admin for mild GI infxns, parenteral for systemic;
 Enters inflamm meninges/CSF;
 Res - plasmid-mediated alteration in binding site;
 Tx - DOC for MRSA, strep, enterococci, 2nd line for C. diff;
 SE - synergistic nephtrotox, ototoxicity (w/ loops), Red Man Syndrome, dec [plasma] in multiple myeloma, GI, phlebitis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - Inh 50S ribosome; Oral admin (100% bioavail), also parenteral;
 Supplement after dialysis;
 Res - pt mutations of 23s RNA ribosome binding site;
 Tx - VRE (E. faecium and faecalis)[static], MRSA [static], strep [cidal];
 SE - N/V, diarrhea, pseudomembranous colitis, inh MAO;
 CI - PKU
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - 30S ribosome - "Tetracycline"; Passive diffusion thru porin channels into cell - ribosome binding;
 Abs (best in stomach) inh by multivalent cations - enters placenta, milk;
 Res - slow, via dec influx & inc efflux;
 Tx [BROAD] - MYCOPLASMA, CHLAMYDIA, RICKETTSIAE, SPIROCHETES, protozoa, lyme, acne, peridontal dz;
 SE - LIVER TOX, PHOTOSENS, TEETH discoloration, (LESS) GI, avitaminosis, vertigo, dec bone growth;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - 50S ribosome - "Macrolide"; Oral admin, STATIC axn;
 Res [cross-res w/ Clinda] - rapid - plasmid-mediated dec influx, target altered, and drug hydrolysis;
 Tx - [NARROW, G+] LEGIONAIRE'S DOC, Pneumociocci, GAS, Listeria, Corynebacterium, Lyme;
 SE - CYP450 inh, cholestatic hepatitis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - 50S ribosome - "Macrolide"; Oral admin, STATIC axn;
 DEC GI EFX, INC ACID STABILITY, INC ABS;
 Res [cross-res w/ Clinda] - rapid - plasmid-mediated dec influx, target altered, and drug hydrolysis;
 Tx - [NARROW, G+] Erythro's plus MAC'S DOC, H.flu, strep, H.pylori, Ct, Moraxella;
 SE - CYP450 inh, cholestatic hepatitis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - 50S ribosome - "Macrolide"; Oral admin, STATIC axn;
 LONG T1/2;
 Res [cross-res w/ Clinda] - rapid - plasmid-mediated dec influx, target altered, and drug hydrolysis;
 Tx - [NARROW, G+] DOC for LEGIONAIRE'S/MAC/CAMPYLOBACTER, H.flu, strep, Ct, Lyme;
 SE - CYP450 inh, cholestatic hepatitis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - 50S ribosome - Sim. mech as macrolides; Penetrates bone, not CSF;
 Acid stable, slow resistance;
 Tx - anerobes (B. FRAGILIS), G+, toxo, P. jiroveci;
 SE - PSEUDOMEMBRANOUS COLITIS, GI, rash
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - 30s ribosome (irrev. dmg) - aminoglycoside; Diffuse through outer porin channel, req energy from ETC for cytoplasmic memb;
 Conc-dependent killing - use bolus dose (parenteral);
 Enters inflamm meninges/CSF, renal cortex, inner ear;
 Limited cross-res within class;
 Tx - [severe aerobic G-] enterococcus endocarditis, MRSA, staph epi;
 SE - ototoxicity (irrev.), nephrotox (PCT, renal cortex), neuromuscluar blockade, teratogen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - 30s ribosome (irrev. dmg) - aminoglycoside; Diffuse through outer porin channel, req energy from ETC for cytoplasmic memb;
 Conc-dependent killing - use bolus dose (parenteral);
 Enters inflamm meninges/CSF, renal cortex, inner ear;
 Limited cross-res within class;
 Tx - [severe aerobic G-] P. aeruginosa;
 SE - ototoxicity (irrev.), nephrotox (PCT, renal cortex), neuromuscluar blockade, teratogen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - 30s ribosome (irrev. dmg) - aminoglycoside; Diffuse through outer porin channel, req energy from ETC for cytoplasmic memb;
 Conc-dependent killing - use bolus dose (parenteral);
 Enters inflamm meninges/CSF, renal cortex, inner ear;
 Limited cross-res within class;
 Tx - [resistant, severe aerobic G-] Klebsiella, Enterobacter, E.coli, 2nd-line TB!;
 SE - ototoxicity (irrev.), nephrotox (PCT, renal cortex), neuromuscluar blockade, teratogen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - folic acid met; Selective for bacterial enz DHFR - prevents reduction of di- to tetra-hydrofolate;
 Penetrates CSF, prostate, vaginal fluid;
 Res - @ DHFR;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - DNA gyrase - 2nd gen fluoroquinolone; Dec abs w/ multivalent cations in antacids;
 Improved PK;
 Inh CTP450;
 Res - dec porin proteins, efflux, or binding site axn;
 Tx - Hi G- systemic axn, intracellular bacteria;
 SE - GI, dizzy, photosens, seizures, crystalluria;
 CI - pregnancy, youth
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Microbial - DNA gyrase - 3rd gen fluoroquinolone; Dec abs w/ multivalent cations in antacids;
 Res - dec porin proteins, efflux, or binding site axn;
 Tx - Improved G+ axn, Broad G-, intracellular bacteria;
 SE - GI, dizzy, photosens, seizures, crystalluria;
 CI - pregnancy, youth
 |  | 
        |  | 
        
        | Term 
 
        | Amphotericin B (Amphocin) |  | Definition 
 
        | Polyene Antifungal - cell membrane; Binds ergosterol, forms pore - leak of K,Mg - Cidal efx;
 IV admin - hi binding to beta-lipoprotein;
 Res - in Candida;
 Tx - [deep fungal in preg., systemics] Candida, Crypto, Aspergillus, Blasto;
 SE - NEPHROTOX, fever, thrombophlebitis, hypersens, shock/hypoT;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal; Prodrug - inh thymidylate synth - inh DNA synth;
 Cidal/static dep. on dose and organism;
 Oral admin - Give with AmphB;
 Res - dec permease, dec cytosine deaminase (no activation of drug);
 Tx - [systemic mycoses] Candida meningitis
 SE - hematological, colitis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal - cell membrane; Inh ergosterol synth;
 Severe CYP450 inh;
 Res - rapid if used alone;
 Tx - [broad] Invasive Aspergillus, Scedosporium, Fusarium;
 SE - VISUAL DISTURB, PHOTOSENS, HEPATOTOX, teratogenic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal - cell membrane; Inh ergosterol synth;
 Mild CYP450 inh;
 Res - rapid if used alone;
 Tx - [broad] yeasts, dermatophytes, systemic mycoses;
 SE - DEC TESTOSTERONE, NO ADRENAL STERIODOGENESIS, teratogenic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal; Inh squalene epoxidase - inh ergosterol synth;
 Highly protein bound - Conc in keratin - hair and nails;
 Oral or topical admin;
 Tx - onychomyosal fungal infxns - nails;
 SE - HA, GI, TASTE CHANGES, CHOLESTATIC HEPATITIS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal; Static - disrupts mitotic spindle;
 Conc in keratin precursor cells;
 CYP450 inducer;
 Tx - dermatophytes;
 SE - HA, GI, photosens;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-mycobacterium - cell wall; Blocks mycolic acid synth - cidal if rapid growth/ static if slow;
 Oral admin;
 Enters inflamm meninges/CSF, placenta, breastmilk;
 Dec efx w/ anatacids, steroids - Met by acetylation;
 Res - rapid, use in combo;
 Tx - first line for TB;
 SE - perhiperal neuropathy, hepatotox, B6 deficiency
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-mycobacterium; Binds beta subunit of RNApol - cidal to intra/extracellular mycobacteria;
 Oral admin - Enters CSF;
 CYP450 inducer;
 Inc lvls if take w/ probenecid;
 Tx - TB (1st line), MRSA, mengingococcus, anti-leprosy;
 SE - orange fluids, GI, fever, hepatotox
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-mycobacterium; Oral admin - Dec abs w/ antacids (Al+++);
 Static;
 Enters placenta, breastmilk, inflamed meninges/CSF;
 Slow resistance;
 Tx - first line TB and MAC;
 SE - optic neuritis, hyperuricemia, allergic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-mycobacterium - aminoglycoside; Targets ribosomes (30S);
 IM admin;
 Tx - first line TB;
 SE - significant toxic profile;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Herbal supplement - Natural coumarin derivative; Interaxn w/ Rx anticoagulants
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Herbal supplement; Contains synephrine, an alpha-1 agonist;
 Inh CYP3A4;
 SE - stroke, angina, ischemic colitis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dietary supplement; Potent antioxidant;
 'Tx' - HTN, ischemic heart disease, prevention of statin-induced myopathy;
 SE - poss warfarin interaxn due to VitK-like structure
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dietary Supplement; 'Tx' to give an Immune boost - no supporting evidence;
 Thus antagonizes immunosuppressants;
 Induces CYP3A4;
 Inhibits CYP1A2 and intestinal 3A4
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Herbal supplement; 'Tx' - dec cholesterol;
 SE - antiplatelet & prolonged bleeding
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Herbal supplement; 'Tx' - preventing AD;
 SE - anti-platelet,
 Inh CYP1A2 and 2D6
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Herbal supplement; Immune boost, CV benefits, dec LDL, dec [glucose];
 Thus antagonizes immunosuppressants;
 Other SE - prolonged bleeding, inh CYP2D6
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Herbal supplement - natural coumarin derivative; Interaxn w/ Rx anticoagulants;
 Estrogen-like axns - inc cancer risk
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Herbal supplement; 'Tx' as a laxative;
 SE - hepatotox and carcinogenic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Herbal supplement; 'Tx' - depression (good evidence);
 Induces CYP3A4, 1A2, 2C9
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mineral supplement; Imp. cofactor in enzymes, protein and carb metabolism;
 Dec childhood diarrhea;
 Healing of gastric ulcers;
 Tx - sickle cell, acne, ADHD, Down's, herpes, hi cholesterol, plaques and gingivitis
 |  | 
        |  | 
        
        | Term 
 
        | Erythropoietin Note! - Epoetin alpha, darbepoetin alpha
 |  | Definition 
 
        | Hematopoietic Growth Factor; Acts on progenitor cell receptor to inc RBC production (BFU-E and CFU-E);
 IV or SC admin;
 Tx - anemia assoc w/ AIDS, chemo, preemies, chronic inflamm dz's, renal failure;
 SE - cardiotox, nephrotox
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Myeloid Growth Factor; Stimulates myelopoiesis of granulocytes, etc.;
 Tx - severe neutropenia;
 SE - granulocyte spike, bone pain, rash
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Myeloid Growth Factor; Stimulates myelopoiesis of granulocytes, etc.;
 Tx - severe neutropenia;
 SE - granulocyte spike, bone pain, rash
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Megakaryocyte Growth Factor; Recombinant IL-11 which inc lymphoid and myeloid growth;
 Tx - thrombocytopenia;
 SE - fatigue, dizzy, dyspnea, arrhhythmia, edema
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mineral Iron; Oral admin;
 Tx - DOC for iron deficiency anemia;
 SE - heartburn, nausea, GI
 |  | 
        |  | 
        
        | Term 
 
        | Vit B12 (Cyanocobalamin and Hydroxycobalamin) |  | Definition 
 
        | Vitamin; Admin parenteral > oral;
 Tx - B12 deficiency (megaloblastic - pernicious anemia)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Vitamin; Oral or parenteral admin;
 Use before preg thru breasfeeding;
 Tx - specific deficiency (think prego, chemo, chronic EtOH, upper intestine dz);
 Counteracts AED's
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CNS stimulant; Indirect dopamine agonist - inc BP, wakefulness, alert, concentration, self-confidence, euphoria, physical perform., wt loss;
 Psychological dependence;
 Tx - obesity, narcolepsy, ADHD;
 SE - arrhythmias, angina, HA, abuse (dopamine reward), neurotoxic, convulsions, cerebral hemorrhage, schizo.
 |  | 
        |  | 
        
        | Term 
 
        | Dex-amphetamine (Dexedrine) |  | Definition 
 
        | CNS stimulant; Indirect dopamine agonist - inc BP, wakefulness, alert, concentration, self-confidence, euphoria, physical perform., wt loss;
 Psychological dependence;
 Tx - obesity, narcolepsy, ADHD;
 SE - arrhythmias, angina, HA,  abuse (dopamine reward), neurotoxic, convulsions, cerebral hemorrhage, schizo.
 |  | 
        |  | 
        
        | Term 
 
        | Methhylphenidate (Concerta) |  | Definition 
 
        | CNS stimulant - mild; Indirect dopamine agonist - inc BP, wakefulness, alert, concentration, self-confidence, euphoria, physical perform., wt loss;
 Tx - narcolepsy, ADHD;
 SE - arrhythmias, angina, HA,  abuse (dopamine reward), neurotoxic, convulsions, cerebral hemorrhage, schizo.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Stimulant; NE reuptake inh - NE agonist;
 Tx - ADHD (esp adults);
 Low abuse potential;
 SE - anorexia, insomnia, inc HR/BP
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Stimulant; DA, NE, serotonin reuptake inh;
 Tx - obesity (<6 mo. use)
 CI - MAOI, anorexia, HTN;
 SE - serotonin syndrome, HTN
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Stimulant - unk mech; No DA effect - no abuse;
 Tx - narcolepsy;
 Induces CYP450;
 SE - HA for 1 week
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Stimulant; Indirect NE and serotonin agonist;
 Tx - short term for obesity;
 Low abuse potential;
 CI - atherosclerosis, HTN, hyperthyroid, CV dz, MAOIs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Activates ATIII to inactivate thrombin and factors IX, X, XI, and XII; Admin SQ or IV;
 Variable t1/2 and binding to other plasma proteins - monitor PTT;
 Works only for soluble thrombin;
 SE - HIT (at 5-10 days);
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Low MW Heparin; Admin SQ;
 Small, long t1/2;
 INC anti-Xa axn, Dec plasma protein binding, and dec anti-platelet action;
 Tx - DVT prophylaxis;
 SE - less potential for HIT (at 5-10 days)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct Thrombin Inhibitor; Irreversibly binds active site and exosite 1 of thrombin;
 Acts on soluble and CLOT-BOUND THROMBIN;
 No immune-med thrombocytopenia;
 Source - leech saliva;
 Tx - HIT;
 SE - (less) hemorrhage;
 CI - renal failure
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct Thrombin Inhibitor; Irreversibly binds active site and exosite 1 of thrombin;
 Acts on soluble and CLOT-BOUND THROMBIN;
 No immune-med thrombocytopenia;
 Source - recombinant form;
 Tx - HIT;
 SE - (less) hemorrhage;
 CI - renal failure
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | VitK Antagonist;
 Competes w/ Vitamin K epoxide reductase - dec K - Blocks activation of factor II, VII, IX, X - dec thrombin formation;
 Slow onset (36-72 hrs), long duration - monitor PT;
 Tx - DVT, PE, Afib, Rheumatic heart dz (DOC for the first 3);
 SE - skin necrosis, hemorrhage, transient pro-coagulant (inh Protein C), drug interactions (incl. EtOH);
 CI - liver disease
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-selective COX1/2 IRREV. Inh - anti-platelet; Acetylation of enzyme;
 COX1 inh - no TXA2 - dec aggregation;
 COX2 inh - no PGI2 - inc aggregation;
 Tx - CHD;
 SE - GI bleed, hemorrhagic stroke, asthma;
 CI - coumarin, PUD;
 Max dose <4g/day
 |  | 
        |  | 
        
        | Term 
 
        | Dipyridamole (Persantine) |  | Definition 
 
        | PDE Inh - anti-platelet; Inc cAMP - inh aggregation (prostacyclin-mediated) and inc adenylate cyclase (dec adenosine);
 Vasodilator;
 Tx - adjunct of aspirin for anti-platelet, adjunct w/ warfarin for prosthetic valves;
 SE - HA, dizzy, GI
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ADP Inhibitor - anti-platelet; Thienopyridine prodrug - activated by CYP2C19 (omeprazole interaxn);
 Prevents ADP-GPIIb/IIIa interaction - no platelet activation;
 Tx - CHD in higher risk pts (not stable CHD), [2nd line to aspirin] prophylaxis for MI, stroke;
 SE - bleeding!;
 CI - surgery
 |  | 
        |  | 
        
        | Term 
 
        | Eptifibidate (Integrelin) |  | Definition 
 
        | GP IIb/IIIa Receptor Block - anti-platelet; Synthetic;
 Prevents binding of fibrinogen or vWF;
 IV admin;
 Tx - non-Qwave MI, prophylaxis during cardiac cath and angioplasty
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GP IIb/IIIa Receptor Block - anti-platelet; Monoclonal Ab that targets the receptor;
 IV admin;
 Tx - prophylaxis during cardiac cath and angioplasty
 |  | 
        |  | 
        
        | Term 
 
        | Streptokinase (Streptase) |  | Definition 
 
        | 1st Gen Thrombolytic; Forms activator complex with plasminogen;
 Non-specific degradation & Streptococcus product = SE's;
 Tx - MI, PE, DVT, thrombotic stroke;
 SE - systemic lytic state, intracranial hemorrhage, immune response (hypoT, bronchospasm, angioedema, serum sick);
 CI - over 75y.o., surgery, HTN, pericarditis;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Gen Thrombolytic; Forms tertiary complex w/ fibrin and plasminogen;
 SPECIFIC AXN (for fibrin) - local axn;
 Tx - MI, PE, or ischemic stroke (w/ no hemorrhage!);
 CI - over 75y.o., surgery, HTN, pericarditis;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 3rd Gen Thrombolytic; r-PA - "small t-PA" (kringle + protease);
 Long t1/2;
 Admin IV bolus;
 SE - inc hemorrhagic stroke;
 CI - over 75y.o., surgery, HTN, pericarditis;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Opiate Anti-diarrheal; Dec secretions, inc muscle tone (ANTISPASMODIC) incl sphincters (dec urgency @external anal sph), dec motility, inc contact time;
 Binds calmodulin;
 CI - fever, blood or mucous in stool
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Weak Inhibitor of COX-1,2,(3); analgesic and antipyretic;
 Limited effects on platelets;
 NOT useful for anti-inflammatory;
 Tx - antipyretic/analgesic for patients taking warfarin or heparin;
 SE - HEPATOTOXICITY, stroke, MI;
 CI - excessive EtOH, >60y.o.(caution);
 Max dose <4g/day
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Expectorant; Oft combined w/ antihistamines, antitussives
 |  | 
        |  | 
        
        | Term 
 
        | Dimenhydrinate (Dramamine) |  | Definition 
 
        | 1st Gen antihistamine - ether deriv; Sedative, anti-emetic, GI cramps, anticholinergic;
 tx allergies, hay fever, rhinitis, urticaria, insect bites, motion sickness & vertigo (antiemetic);
 SE - sedation, dystonia, nasal congestion;
 CI - asthma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antitussive - cough suppression; Opiate derivative but non-narcotic;
 No analgesia;
 Met at CYP2D6;
 acts on non-opioid receptors;
 SE - hallicinogen, dry mouth, tachycardia, disorientation, depersonalization, somnolence
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Irreversible Anticholinesterase; Tx resistant scabies and pediculosis;
 Remember: acetylcholinesterase inhibitor (insecticide);
 SE - systemic ingestion=cholinergic effects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Benzodiazepine - balanced anesthesia; Inc activity of GABA receptor/channel;
 Death from OD more diff than with barbs;
 No analgesia;
 Anticonvulsant, anterograde amnesia, balancing sympathomimetic effects, wide safety margin;
 (Flumazenil = specific BZ antagonist)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antibiotic; Give enema to dec colonic bacteria;
 Tx - portal HTN, encephalopathy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anticholinergic; Sedation and amnesia;
 Pre-op ancillary agent for anesthesia;
 Tx reflex bradycardia, block muscarinic anticholinesterases (NM blocker OD);
 Drying of secretions;
 Blocks pathways from inner ear;
 Tx motion sickness
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-1 and 2 antagonist; direct effect on Na channels, anti-arrythmias;
 tx HTN, esp with CHF or prev MI;
 SE see BB SEs
 |  | 
        |  |